Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study

JAMA

Volumn 276, Issue 2, 1996, Pages 105-110

  O'Brien, Thomas R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RNA ANALYSIS; SEROCONVERSION; VIRUS DETECTION; VIRUS TITRATION;

EID: 0029683640     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.2.105     Document Type: Article

References (28)

1. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multiccnter evaluation of quantification methods of plasma human immunodeficiency virus type 1RNA, J Infect Dis. 1994;170:553-562.
2. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-964.
3. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA. 1995; 274:554-558.
4. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitäten of HIV-IRNAin plasma predicts outcome after seroconversion. Ann Intern Med. 1995;122:573-579.
5. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989; 321:1141-1148.
6. Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ, for the Multicenter Hemophilia Cohort Study. HIV-1 infection incidence among persons with hemophilia in the United States and Western Europe, 1978-1990. JAcquir Immune Defic Syndr. 1994;7279-286.
7. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987;107:l-6.
8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol. 1994;32:292-300.
9. Fletcher MA, Baron GC, Ashman MR, Fischl MA, Klimas NG. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol. 1987;5:69-81.
10. Tollerud DJ, Brown LM, Clark JW, et al. Cryopreservation and long-term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis: effects on cell subset proportions and fluorescence intensity. J Clin Lab Anal. 1991;5:255-261.
11. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1987;36(suppl 1S):1S-15S.
12. Armitage P. Statistical Methods in Medical Research. Oxford, England: Blackwell Scientific Publications; 1971:396-398.
13. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, Version 5: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Stone Mountain, Ga: USD Inc; 1990.
14. Thomas DG, Breslow N, Gart JJ. Trend and homogeneity analysis of proportions and life table data, version 2.12. Comput Biomed Res. 1977;10:373-381.
15. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B. 1972;34:187-230.
16. SAS Institute Inc. SAS/STAT Software: Changes and Enhancements, Release 6.07. Gary, NC: SAS Institute Inc; 1992:433-480. SAS technical report P-229.
17. Jurriaans S, van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology. 1994204:223-233.
18. Horton R. Will Duesberg now concede defeat? Lancet. 1995;346:656.
19. Duesberg PH. Is HIV the cause of AIDS? Lancet. 1995;346:1371-1372.
20. Hill AB. The environment and disease: association or causation. Proc R Soc Med. 1965;58:295-300.
21. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994; 68:4650-4655.
22. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271:324-328.
23. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med. 1996;334:426-431.
24. Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL, for the Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilie siblings. AIDS. 1995;9:275-280.
25. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co Inc; 1986:94.
26. Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HI V) infection. Ann Intern Med. 1990;112:727-737.
27. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med. 199022:941-949.
28. Goedert JJ, Cohen AR, Kessler CM, et al. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Lancet. 1994;344: 791-792.